Grasil

Grasil is a prescription medication that contains the active ingredient sildenafil, supplied in an oral dosage form. While the specific strength is not disclosed, the product is marketed within the European Union and is classified as a phosphodiesterase type 5 (PDE5) inhibitor. Grasil works by modulating enzymatic activity to affect vascular smooth muscle tone, and it is intended for use under medical supervision according to clinical guidelines.

Grasil is primarily used in clinical practice for conditions that benefit from enhanced blood flow mediated by PDE5 inhibition.

- Treatment of erectile dysfunction in adult males. - Management of pulmonary arterial hypertension in settings where off‑label use is permitted. - Investigational application in certain cardiovascular disorders where vasodilation is desired. - Adjunct therapy for selected patients with benign prostatic hyperplasia who also experience sexual dysfunction.

Like other sildenafil‑containing products, Grasil may be associated with a range of adverse effects that vary in frequency and severity.

Common: - Headache, often described as mild to moderate. - Flushing or warmth in the face and upper chest. - Indigestion or dyspepsia. - Nasal congestion or a runny nose. - Visual disturbances such as a blue‑tinted vision.

Serious: - Sudden loss of vision (non‑arteritic anterior ischemic optic neuropathy). - Sudden loss of hearing or ringing in the ears. - Prolonged erection lasting more than four hours (priapism). - Severe hypotension, especially when combined with nitrates. - Cardiovascular events such as myocardial infarction or stroke in high‑risk individuals.

Patients should consider several safety factors before starting Grasil, and ongoing monitoring may be required.

- Evaluate cardiovascular health, particularly in patients with known heart disease. - Avoid use in individuals taking nitrates or nitric‑oxide donors due to risk of severe hypotension. - Use caution in patients with severe liver or kidney impairment, as drug clearance may be altered. - Discuss any history of retinal disorders or sudden vision loss with a healthcare professional. - Inform the prescriber of any prior episodes of priapism or prolonged erections. - Pregnant or breastfeeding individuals should not use Grasil, as safety has not been established.

Grasil can interact with several medication classes, influencing its efficacy or safety profile.

Avoid: - Nitrates (e.g., nitroglycerin, isosorbide dinitrate) because of additive blood‑pressure lowering effects. - Certain potent CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, ritonavir) which can increase sildenafil concentrations.

Use with caution: - Alpha‑blockers (e.g., tamsulosin) due to possible additive hypotensive effects. - Other antihypertensive agents, especially when dose‑adjusted. - Medications that affect QT interval, although the risk is low. - Herbal supplements such as St John’s wort that may alter CYP3A4 activity.